Inventor · disambiguated record
Alice V. Bakker
Also filed as: BAKKER ALICE · BAKKER ALICE V
19 granted patents·13 pending applications·153 citations·filing 2005–2023
93Inventor score
Top patents by PatentIndex Score
32 records- 0197US11254729B2IL-7R-α binding compoundsMEDIKINE INC·Filed 2021·Granted Feb 22, 2022·5 cites·9 claims
- 0297US11248030B2Dual IL-2R and IL-7R binding compoundsMEDIKINE INC·Filed 2020·Granted Feb 15, 2022·8 cites·20 claims
- 0396US11746139B2IL-7Rαγc binding compoundsMEDIKINE INC·Filed 2021·Granted Sep 5, 2023·4 cites·37 claims
- 0496US10703776B2IL-2RBeta binding compoundsMEDIKINE INC·Filed 2019·Granted Jul 7, 2020·9 cites·27 claims
- 0596US10689417B2IL-2Rγ binding compoundsMEDIKINE INC·Filed 2019·Granted Jun 23, 2020·10 cites·27 claims
- 0695US8372952B2Binding proteins that bind to human FGFR1C, human β-klotho and both human FGFR1C and human β-klothoAMGEN INC·Filed 2010·Granted Feb 12, 2013·39 cites·31 claims
- 0794US7803907B2c-MET kinase binding proteinsAMGEN MOUNTAIN VIEW INC·Filed 2005·Granted Sep 28, 2010·53 cites·19 claims
- 0891US11999771B2IL-7Rαγc ligand immunoglobulin fusion proteinsMEDIKINE INC·Filed 2022·Granted Jun 4, 2024·1 cites·29 claims
- 0991US7968681B2c-MET kinase binding proteinsAMGEN MOUNTAIN VIEW INC·Filed 2010·Granted Jun 28, 2011·11 cites·6 claims
- 1086US11548914B2IL-2Rgamma binding compoundsMEDIKINE INC·Filed 2020·Granted Jan 10, 2023·1 cites·30 claims
- 1186US10597456B2Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2017·Granted Mar 24, 2020·6 cites·46 claims
- 1284US2023192767A1Il-2rgamma binding compoundsMEDIKINE INC·Filed 2022·Application pending·0 cites
- 1381US7820790B2IL-6 binding proteinsAMGEN MOUNTAIN VIEW INC·Filed 2007·Granted Oct 26, 2010·4 cites·27 claims
- 1481US2022275026A1Il-2rbeta binding compoundsMEDIKINE INC·Filed 2022·Application pending·0 cites
- 1578US7786262B2IL-6 binding proteinsAMGEN MOUNTAIN VIEW INC·Filed 2006·Granted Aug 31, 2010·2 cites·46 claims
- 1675US11965015B2IL-7R-α-γ binding compoundsMEDIKINE INC·Filed 2023·Granted Apr 23, 2024·0 cites·28 claims
- 1773US2023331855A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 1873US2023331801A1Il-2r-beta-gamma binding compoundsMEDIKINE INC·Filed 2023·Application pending·0 cites
- 1972US11692009B2IL-2alpha receptor subunit binding compoundsMEDIKINE INC·Filed 2022·Granted Jul 4, 2023·0 cites·20 claims
- 2072US11358986B2IL-2RBETA binding compoundsMEDIKINE INC·Filed 2020·Granted Jun 14, 2022·0 cites·30 claims
- 2168US11718654B2IL-2R-βγ binding compoundsMEDIKINE INC·Filed 2020·Granted Aug 8, 2023·0 cites·22 claims
- 2268US2024101959A1Use of il-2r-beta-gamma agonist peptides in cell manufacturingMEDIKINE INC·Filed 2023·Application pending·0 cites
- 2367US2022119493A1Il-7r-alpha binding compoundsMEDIKINE INC·Filed 2022·Application pending·0 cites
- 2467US2022119465A1Dual il-2r and il-7r binding compoundsMEDIKINE INC·Filed 2022·Application pending·0 cites
- 2566US2024158457A1Interleukin-18 receptor binding polypeptides and uses thereofMEDIKINE INC·Filed 2023·Application pending·0 cites
- 2666US2023124464A1Chimeric receptors to flt3 and methods of use thereofAMGEN INC·Filed 2022·Application pending·0 cites
- 2764US2020115457A1Chimeric receptors and methods of use thereofKITE PHARMA INC·Filed 2019·Application pending·0 cites
- 2864US2024100159A1Use of il-7r-alpha-gamma agonist peptides in cell manufacturingMEDIKINE INC·Filed 2023·Application pending·0 cites
- 2961US11248025B2IL-2alpha receptor subunit binding compoundsMEDIKINE INC·Filed 2020·Granted Feb 15, 2022·0 cites·26 claims
- 3059US2022119492A1Il-2r-beta-gamma binding compounds and uses thereofMEDIKINE INC·Filed 2021·Application pending·0 cites
- 3155US9708375B2Inhibitory polypeptides specific to WNT inhibitorsAMGEN INC·Filed 2014·Granted Jul 18, 2017·0 cites·10 claims
- 3249US2013197191A1Binding Proteins That Bind to Human FGFR1c, Human Beta-Klotho and Both Human FGFR1c and Human Beta-KlothoAMGEN INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →